Navigating legal and regulatory landscape of GLP-1 drugs in India
India is currently facing a growing public health issue, with recent data showing that nearly a quarter of the adult population is…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Regulatory
Kotak Alts invests INR 200 Million in Cellogen Therapeutics
Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Sciences Fund I (KLSF-I), which invests in early- to…
Industrial and infrastructure sectors are undergoing rapid modernisation
How critical is infrastructure automation in pharma facilities?
Infrastructure is integral to maintaining controlled…
Our goal is to help companies reduce cost per cubic meter of wastewater treatment
The pharma industry is considered one of the most polluting industries, not just in India, but across the world. Antibiotics have…
Nimesulide and patient safety: Lessons from global drug regulation
Recently, the Indian Ministry of Health and Family Welfare issued a government resolution banning the use of Nimesulide above 100…
DISSO India 2025 kicks off in Mumbai, showcasing global advances in dissolution science
The Society for Pharmaceutical Dissolution Science (SPDS) today inaugurated the 13th Annual DISSO India Symposium, one of the most…